Néoplasie

Fr | De

Feedback | Impressum | Sitemap

Aucun choix d'articles!

Panier

Vous êtes ici: Recherche de documentation spécialisée » Foie » Néoplasie

23. Février 2025

Dépistage / diagnostic

Recherche de documentation spécialisée

Écriture:

Page 1 de 3544


	Articles 1 - 20 / 70863

	The Role of 3D Printing and Augmented Reality in the Management of Hepatic Malignancies. Technol Cancer Res Treat Karageorgos FF, Karolos IA, Pettas T, Tsioukas V, Pikridas C, Tsoulfas G. PMID: 39980434 [PubMed - indexed for MEDLINE]
	Novel histone modifications and liver cancer: emerging frontiers in epigenetic regulation. Clin Epigenetics Wang Z, Liu Z, Lv M, Luan Z, Li T, Hu J. PMID: 39980025 [PubMed - indexed for MEDLINE]
	Predicting hepatocellular carcinoma survival with artificial intelligence. Sci Rep Seven , Bayram D, Arslan H, Kö, Gümü, Aktürk Esen S, , , Uncu D. PMID: 39979406 [PubMed - indexed for MEDLINE]
	Evaluation of the long-term outcomes of patients with hepatitis delta. J Infect Dev Ctries Tarhan MS, Gedik H, Kart-Yasar K. PMID: 39977478 [PubMed - indexed for MEDLINE]
	Impact of HIV Infection on Hepatocellular Carcinoma: A Long-Term Prognostic Analysis. J Laparoendosc Adv Surg Tech A Diao YH, Gong FP, Cheng Y. PMID: 39976506 [PubMed - indexed for MEDLINE]
	BioPearlâ„¢ doxorubicin microspheres for unresectable HCC: a prospective, single-arm, multicenter study: BIOPEARL-ONE. Future Oncol Verset G, Iezzi R, Bargellini I, Bucalau AM, Pereira P, Groezinger G, Spreafico C, Maleux G. PMID: 39972606 [PubMed - indexed for MEDLINE]
	(18)F-FDG PET/CT-based intratumoral and peritumoral radiomics combining ensemble learning for prognosis prediction in hepatocellular carcinoma: a multi-center study. BMC Cancer Sui C, Chen K, Ding E, Tan R, Li Y, Shen J, Xu W, Li X. PMID: 39972270 [PubMed - indexed for MEDLINE]
	Therapeutic outcomes of thermal ablation versus repeated hepatic resection for recurrent hepatocellular carcinoma by using propensity score analysis: a multicenter real-world study. BMC Cancer Zhang K, Wang W, Mu L, Xie L, Li M, Yang W, Jiang T. PMID: 39972245 [PubMed - indexed for MEDLINE]
	Updated insights into the impact of adjuvant chemotherapy on recurrence and survival after curative resection of liver or lung metastases in colorectal cancer: a rapid review and meta-analysis. World J Surg Oncol Tatsuta K, Sakata M, Kojima T, Booka E, Kurachi K, Takeuchi H. PMID: 39966950 [PubMed - indexed for MEDLINE]
	Stereotactic body radiotherapy with carbon ions as local ablative treatment in patients with primary liver cancer. Radiat Oncol Hoffmeister-Wittmann P, Hoegen-Saßmannshausen P, Wicklein L, Weykamp F, Seidensaal K, Springfeld C, Dill MT, Longerich T, Schirmacher P, Mehrabi A, Mathy RM, Köhler BC, Debus J, Herfarth K, Liermann J. PMID: 39966902 [PubMed - indexed for MEDLINE]
	Integration of single-cell and spatial transcriptomics reveals fibroblast subtypes in hepatocellular carcinoma: spatial distribution, differentiation trajectories, and therapeutic potential. J Transl Med Liu Y, Dong G, Yu J, Liang P. PMID: 39966876 [PubMed - indexed for MEDLINE]
	G2M-checkpoint related immune barrier structure and signature for prognosis and immunotherapy response in hepatocellular carcinoma: insights from spatial transcriptome and machine learning. J Transl Med Chen X, Wu S, He H, Tang J, Zhong Y, Fang H, Huang Q, Hong L, Shao L, Wu J. PMID: 39966861 [PubMed - indexed for MEDLINE]
	Multi-omics integration analysis of the amino-acid metabolism-related genes identifies putatively causal variants of ACCS associated with hepatitis B virus-related hepatocellular carcinoma survival. BMC Cancer Wei X, Yang X, Duan S, Lin Q, Qiu M, Wen Q, Mo Q, Zhou Z, Jiang Y, Chen P, Liang X, Cao J, Guo Q, Yu H, Liu Y. PMID: 39966747 [PubMed - indexed for MEDLINE]
	Development and clinical validation of a novel platelet count-based nomogram for predicting microvascular invasion in HCC. Sci Rep Zheng W, Chen H, Zhang J, He K, Zhu W, Chen X, Yan X, Lin Z, Yang Y, Wang X, Li H, Zhu S. PMID: 39966444 [PubMed - indexed for MEDLINE]
	Mitochondrial alterations and signatures in hepatocellular carcinoma. Cancer Metastasis Rev Chen TH, Lin SH, Lee MY, Wang HC, Tsai KF, Chou CK. PMID: 39966277 [PubMed - indexed for MEDLINE]
	Intraindividual crossover comparison of gadobenate dimeglumine-enhanced and gadoxetate disodium-enhanced MRI for characterizing focal liver lesions. Eur Radiol Exp Tang W, Xiao Y, Kuang S, Rong D, He B, Grazioli L, Hussain SM, Wang J. PMID: 39966271 [PubMed - indexed for MEDLINE]
	Imaging-Based Prediction of Ki-67 Expression in Hepatocellular Carcinoma: A Retrospective Study. Cancer Med Cai C, Wang L, Tao L, Zhu H, Ren Y, Li D, Li D. PMID: 39964132 [PubMed - indexed for MEDLINE]
	Application of CT-based radiomics combined with laboratory tests such as AFP and PIVKA-II in preoperative prediction of pathologic grade of hepatocellular carcinoma. BMC Med Imaging Wu M, Yu H, Pang S, Liu A, Liu J. PMID: 39962429 [PubMed - indexed for MEDLINE]
	Selective internal radiation therapy for neuroendocrine liver metastases: efficacy, safety and prognostic factors. A retrospective single institution study. Acta Gastroenterol Belg Briol D, Ceratti A, Lhommel R, Annet L, Dragean C, Danse E, Trefois P, Van Den Eynde M, De Cuyper A, Goffette P, Borbath I. PMID: 39961293 [PubMed - indexed for MEDLINE]
	Bulevirtide in Chronic Hepatitis D Patients Awaiting Liver Transplantation Results From a French Multicentric Retrospective Study. Liver Int Meszaros M, Hilleret MN, Dumortier J, D'Alteroche L, Abergel A, Latournerie M, Antonini T, Conti F, Borentain P, Dharancy S, Pageaux GP. PMID: 39960163 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 70863

Page 1 de 3544



		Intervalle de temps demandé

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy \| Publicité